UnknownNot Applicable

Analgesic Efficacy of Capsaicin 8% Patch (QUTENZA®) in Coccygodygnia

106 participantsStarted 2023-08-15

Plain-language summary

A retrospective study over a period of 6 years to explore analgesic efficacy of 8% Capsaicin patch (QUTENZA®) in coccygodynic patients, as well as neuropathic predictive factors of therapeutic response.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who received topical Capsaicin 8% patch therapy for the treatment of their coccygodygnia between August 2016 and August 2022 Exclusion Criteria: * Patients who have already received 8% Capsaicin patch topical treatment in coccyx area.

What they're measuring

Responder rate

Timeframe: 3 months after the inclusion visit.

Trial details

NCT IDNCT05983263

SponsorNantes University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-17

View on ClinicalTrials.gov More Coccyx Disorder trials